Dermatology
RSSArticles
-
Spironolactone for Heart Failure
The authors concluded that in a diverse, community-based population with new systolic heart failure, spironolactone did not reduce death or hospitalization, but did increase the incidence of hyperkalemia. -
Infectious Disease Malpractice: The $1.2 Million Miscommunication
-
Two-step Screening for Ovarian Cancer: A ‘Scissor-step’ Forward?
-
Improving Adherence: Who's Doing the Work?
Approximately 50% of patients with chronic illnesses do not adhere to indicated medications, treatment regimens, and healthy lifestyle changes.
-
Side Effects of Opioids
Constipation is the most commonly reported side effect with opioid therapy. Tolerance does not generally develop. Most patients on chronic opioid therapy require prophylaxis -
Hypertension in the Elderly May Be Associated with Progressive Brain Atrophy
-
Is ‘Silent’ Atrial Fibrillation in Diabetics Associated with Cerebral Neurologic Events?
-
Are Hospitalists Associated with Improvements in Quality of Care?
This study demonstrates an association between the use of hospitalists by a hospital and a reduction in 30-day excess readmission rates for heart failure, acute myocardial infarction, and pneumonia. -
Pharmacology Update: Droxidopa Capsules (Northera)
A new drug for the treatment of neurogenic orthostatic hypotension (NOH) has been approved by the FDA under its accelerated approval program. Droxidopa is a prodrug to norepinephrine. -
Clinical Briefs
The consequences of vitamin b12 (B12) deficiency most commonly include neurologic (CNS and peripheral nervous system) and hematologic (megaloblastic anemia).